RPRX: Royalty Pharma plc – Class A Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 12,714.84
Enterprise Value ($M) 22,355.13
Book Value ($M) 9,585.10
Book Value / Share 21.55
Price / Book 1.33
NCAV ($M) -4,541.82
NCAV / Share -10.21
Price / NCAV -2.80

Profitability (mra)
Return on Invested Capital (ROIC) 0.01
Return on Assets (ROA) 0.01
Return on Equity (ROE) 0.02

Liquidity (mrq)
Quick Ratio 13.51
Current Ratio 13.51

Balance Sheet (mrq) ($M)
Current Assets 1,728.61
Assets 15,855.52
Liabilities 6,270.43
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A General Atlantic Llc 5.60 0.00
02-10 13G/A Morgan Stanley 9.90 -21.85
02-09 13G/A Adage Capital Partners Gp, L.l.c. 1.59 -71.82
02-09 13G/A Fmr Llc 10.00 99.78
02-09 13G/A Vanguard Group Inc 8.08 20.22

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-02-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2023-12-08 91,725 1,028,014 8.92
2023-12-07 273,182 1,763,843 15.49
2023-12-06 383,445 2,393,563 16.02
2023-12-05 194,356 1,585,593 12.26
2023-12-04 316,365 2,484,973 12.73

(click for more detail)

Similar Companies
RNXT – RenovoRx Inc ROIV – Roivant Sciences Ltd
RPHM – Reneo Pharmaceuticals Inc RPTX – Repare Therapeutics Inc
RTVA – Artiva Biotherapeutics Inc


Financial data and stock pages provided by
Fintel.io